July 12th 2024, 7:00pm
By Alex Biese
One expert from the University of Colorado Cancer Center explains the multidisciplinary aspect of sarcoma care to maximize patients’ functioning.
July 12th 2024, 5:00pm
By Karen Cohn
Having a check-up appointment without receiving any type of scan is good, but also scares me.
July 12th 2024, 3:00pm
By Ashley Chan
From a TODAY contributor opening up about breast reconstruction surgery to Arizona rep. Raúl Grijalva completing cancer treatment, here’s what’s going on in the oncology space this week.
July 12th 2024, 1:00pm
By Lorna Morgan
I was diagnosed with myeloma more than two decades ago and am lucky to have support throughout.
July 11th 2024, 9:00pm
Results from a phase 2/3 study demonstrated that paxalisib led to a 3.8-month survival improvement in some patients with glioblastoma.
July 11th 2024, 7:00pm
A novel intratumoral treatment was administered to the first patient in a phase 3 trial for certain patients with metastatic soft tissue sarcoma.
July 11th 2024, 5:00pm
By Ronald Chin
Side effects from multiple myeloma, such as six inches of collapsed vertebrae, have made me adjust my lifestyle, but I make the most of what I can.
July 11th 2024, 3:00pm
Patients with favorable-risk prostate cancer “should be aware that they don't need treatment right away,” one expert said.
July 11th 2024, 1:00pm
By Karen Kosky
Whenever I received bad news regarding my colorectal cancer, I felt like it was the end — until my therapist told me something that changed everything.
July 10th 2024, 9:00pm
By Brielle Benyon
Dana Frost, a cancer survivor and grief advocate, said writing about survivors’ guilt and connecting with others feeling the same way was therapeutic.
July 10th 2024, 7:00pm
During summer 2024, there have been many changes made in the non-small cell lung cancer and small cell lung cancer spaces. Here are four top news stories.
July 10th 2024, 5:00pm
By Jane Biehl Ph.D.
Although MDS didn’t leave physical scars, the invisible ones, like side effects from treatment, are ones that linger.
July 10th 2024, 3:00pm
The TIL therapy OBX-115 ‘may have the potential to address’ an unmet need among patients with metastatic or locally advanced melanoma.
July 10th 2024, 1:00pm
By Kim Green
I spent a lot of time after my metastatic breast cancer diagnosis worrying of each experience would be my last. Then I had an epiphany.
July 9th 2024, 9:00pm
The Food and Drug Administration granted a fast track designation to ADI-270, an off-the-shelf CAR-T cell therapy for clear cell renal cell carcinoma.
Challenging Assumptions About Cancer and Its Treatments
Sharing Stories of Survivorship
Perioperative Therapy in Resectable NSCLC: The Drive for a Cure
How My Daughter Stood Up to Breast Cancer